Add Company
Join Now

Vascular Therapies Revenue and Competitors

License our Company Data API

Cresskill, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vascular Therapies's estimated annual revenue is currently $703.5k per year.(i)
  • Vascular Therapies's estimated revenue per employee is $100,500

Employee Data

  • Vascular Therapies has 7 Employees.(i)
  • Vascular Therapies grew their employee count by 0% last year.

Vascular Therapies's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
vp OperationsReveal Email/Phone
3
VP, New Product DevelopmentReveal Email/Phone
4
VP Quality AssuranceReveal Email/Phone
5
 Chief Scientific OfficerReveal Email/Phone
6
Senior DirectorReveal Email/Phone
7
DIR OF CLINICAL AFFAIRSReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is Vascular Therapies?

Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery. Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$703.5k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M8-20%N/A
#2
$1.5M17-11%N/A
#3
$2.4M220%N/A
#4
$6.9M340%N/A
#5
$6.7M530%N/A